We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
1
1.Tohen, MF, Baker, RW, Altshuler, LL et al. , Olanzapine versus divalproex in acute mania. Am J Psychiatry.2002;159:1011–1017.CrossRefGoogle ScholarPubMed
2
2.Zajecka, JM, Weisler, R, Sachs, G, Swann, AC, Wozniak, P, Sommerville, KW. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry.2002;63:1148–1155.CrossRefGoogle ScholarPubMed
3
3.Soutullo, CA, DelBello, MP, Ochsner, JE et al. , Severity of bipolarity in hospitalized manic adolescents with history of stimulant or antidepressant treatment. J Affect Disord.2002;70:323–327.CrossRefGoogle ScholarPubMed
4
4.Scheffer, RE, Kowatch, RA, Carmody, T, Rush, AJ. A randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder with mood stabilization with divalproex sodium. Am J Psychiatry.2005;162:58–64.CrossRefGoogle ScholarPubMed